CEL-SCI (FRA:LSR) Common Stock: €0.07 Mil (As of Mar. 2026)


FRA:LSR CEL-SCI Corp FRA:LSR
30 GF Score
Price €0.76
! 2 Warning Signs
View Full Analysis

What is CEL-SCI Common Stock?

CEL-SCI FRA:LSR -9.52% 30 Common Stock is €0.07 Mil as of Mar. 2026. GuruFocus rates FRA:LSR with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

CEL-SCI's quarterly common stock increased from Sep. 2025 (€0.07 Mil) to Dec. 2025 (€0.07 Mil) and increased from Dec. 2025 (€0.07 Mil) to Mar. 2026 (€0.07 Mil).

CEL-SCI's annual common stock declined from Sep. 2023 (€0.44 Mil) to Sep. 2024 (€0.02 Mil) but then increased from Sep. 2024 (€0.02 Mil) to Sep. 2025 (€0.07 Mil).

CEL-SCI Common Stock Historical Data

* Premium members only.

The historical data trend for CEL-SCI's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CEL-SCI Common Stock Chart

CEL-SCI Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.44 0.44 0.02 0.07

CEL-SCI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.05 0.07 0.07 0.07
FRA:LSR
30GF Score
CEL-SCI Corp FRA:LSR
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CEL-SCI Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.07 Mil mean?
CEL-SCI (FRA:LSR) has a Common Stock of €0.07 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on CEL-SCI and its competitors.
Is CEL-SCI's Common Stock too high?
CEL-SCI's current Common Stock is €0.07 Mil. Overall, CEL-SCI has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does CEL-SCI's Common Stock compare to OTLC and AEON?
CEL-SCI's Common Stock of €0.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on CEL-SCI and its competitors. CEL-SCI's current Common Stock is €0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CEL-SCI stock overvalued right now?
CEL-SCI (FRA:LSR) has a current Common Stock of €0.07 Mil. The current Common Stock is €0.07 Mil. CEL-SCI's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For CEL-SCI (FRA:LSR), the current Common Stock is €0.07 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CEL-SCI Business Description

Other Exchanges CVM:USA
Address 8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
30GF Score

Get the complete analysis for FRA:LSR

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price